Jeffrey A Gibala, Regis J Nero, Steven P Day, Matthew G Cimbala, Roger A Smith: Power distribution monitoring system and method. Tollgrade Communications, The Webb Law Firm, November 22, 2011: US08065099 (167 worldwide citation)

A power distribution monitoring system includes a number of power line mounted monitors. Each monitor can acquire data regarding the delivery of electrical power in the power line, wirelessly transmit and receive messages, and electromagnetically acquire and store operating electrical power from ele ...

Mauricio Breternitz Jr, Roger A Smith: Method and apparatus for sequencing computer instruction execution in a data processing system. Motorola, Keith E Witek, March 30, 1999: US05889999 (60 worldwide citation)

A method and apparatus for sequencing computer instructions in memory (24) to provide for more instruction efficient execution by a central processing unit (CPU) (22) begins by executing the computer instructions via the CPU (22) and creating a trace file (FIG. 2) in memory (24). The trace file is t ...

Roger A Smith: Floating point data processor and a method for performing a floating point square root operation within the data processor. Motorola, Keith E Witek, January 31, 1995: US05386375 (60 worldwide citation)

A method and apparatus used for performing a floating pointing operation has the ability to calculate a square root of a number. An approximation to the inverse of the square root of the number is provided via a step (18). Steps (20 and 22) are used to improve the precision of the inverse of the squ ...


Alexander Krantz, Heinz W Pauls, Roger A Smith, Robin W Spencer: Aryloxy and arylacyloxy methyl ketones as thiol protease inhibitors. Syntex, Carol J Roth, Derek P Freyberg, Tom M Moran, October 8, 1991: US05055451 (52 worldwide citation)

Thiol protease inhibitors are disclosed having the formula: ##STR1## or an optical isomer thereof, or a pharmaceutically acceptable salt thereof, wherein:


Paardeep K Sood, Roger A Smith, Timothy J Heeter, Adriano Roganti, John D Acton: Method and apparatus for sharing information between a plurality of processing units. Encore Computer Corporation, Fleit Jacobson Cohn Price Holman & Stern, September 8, 1992: US05146607 (40 worldwide citation)

A plurality of processing units, each having a local memory connected thereto is disclosed. A write sense controller is also connected to each of the processing units to transmit a memory write word into a shared portion of local memory over a reflective memory line. Other write sense controllers re ...

Perry P He, Roger A Smith, Lucio F C Pessoa, Roman A Dyba: Monitoring and control of an adaptive filter in a communication system. Freescale Semiconductor, Joanna G Chiu, Susan C Hill, July 10, 2007: US07242762 (34 worldwide citation)

A communication system having an echo canceller is disclosed. One embodiment of the echo canceller includes an adaptive filter used to provide an estimate of reflected echo which is removed from the send signal. The echo canceller may also include a near-end talker signal detector which may be used ...

Raimund H Silva, Paul R Resnick, Roger A Smith: Solutions of sulfonyl fluoride compounds and fluoropolymers. E I Du Pont de Nemours and Company, September 7, 1982: US04348310 (33 worldwide citation)

Solutions are disclosed with solvents having completely halogenated, saturated, hydrocarbon backbones and solubility parameters within a particular range. Preferred solvent have at least one ether linkage. An exemplary solvent is ##STR1## wherein X is F, Cl, Br, and I; n is 0, 1, and 2; m is 1, 2, a ...

Jacques Dumas, Uday Khire, Timothy B Lowinger, Bernard Riedl, William J Scott, Roger A Smith, Jill E Wood, Holia Hatoum Mokdad, Jeffrey Johnson, Aniko Redman, Robert Sibley: Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas. Bayer Pharmaceuticals Corporation, Millen White Zelano & Branigan P C, February 12, 2008: US07329670 (31 worldwide citation)

The compounds are aryl and heteroaryl substituted heterocyclic ureas of the formula A—NH—C(O)—NH—B where A is the aryl or hetaryl substituted heterocyclic group and B is an aryl or heteroaryl moiety. The compounds inhibit raf kinase and are useful in the treatment of RAF kinase mediated diseases.